HIGHLIGHTS
- who: Saifeddine Melki from the Department of Nuclear, France have published the article: Targeted therapy monitoring of BRAF-V600-mutant Erdheim-Chester disease by fast quantitative whole-body bone CZT-tomoscintigraphies, in the Journal: (JOURNAL)
- how: Bone scintigraphy provided by this VERITON CZT-SPECT/CT system was applied here for the longitudinal monitoring of an ECD patient under treatment.
SUMMARY
Both reliable SUV measurements and high-quality bone scintigraphy images (Melki et_al 2020; Bahloul et_al 2021; Mairal et_al 2022). A threshold of 7.5 SUV was additionally shown to grossly separate . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.